Cytosorbents Corporation

0.85 USD
-0.12 (-12.15%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Cytosorbents Corporation stock is up 6.25% since 30 days ago. The next earnings date is Jul 30, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 9 May’s closed higher than April. 0% of analysts rate it a buy.

About Cytosorbents Corporation

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices. Its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals.